Skip to content

Visual Snow: Studying the visual snow phenotype and shared mechanisms with migraine pathophysiology

Visual Snow: Studying the visual snow phenotype and shared mechanisms with migraine pathophysiology - SNOW Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON45361
Enrollment
250
Registered
2017-11-20
Start date
2018-03-06
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

visual snow

Interventions

clinical description
cortical hyperexcitability
migraine
visual snow

Sponsors

Neurologie
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: General * Age *18 years (and

Exclusion criteria

Exclusion criteria: General exclusion criteria for those willing to participate in case-control measurements * Subjects who do not want to be informed about unexpected findings that are considered serious and have prognostic or therapeutic consequences * Schizophrenia, bipolar disorder, other psychotic disorders in medical history or current clinical suspicion of psychosis (delusions) * Malignancy in medical history * Central nervous system disease in medical history (other than migraine) * For those participating in MRS: Pacemaker or ICD, Metal implants which cannot be removed, Pregnancy, Claustrophobia;Visual snow * Underlying neurological disorder or ophthalmological disorder explaining symptoms (for case-control measurements only (3.2), not an exclusion criterion for clinical description (3.1)) ;HPPD * Underlying neurological disorder or ophthalmological disorder explaining symptoms (for case-control measurements only (3.2), not an exclusion criterion for clinical description (3.1)) * Clinical suspicion that visual symptoms are part of psychosis, delirium, neurodegenerative disease or hypnopompic hallucinations ;Migraine patients with frequent auras * Meeting criteria for any other (comorbid) headache disorder except for tension type headache * Clinical suspicion that patient has Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL; often presents with frequent auras) or any other hereditary cerebral amyloid angiopathy * (History of) ophthalmological disease other than refraction error * (History of) chronic tinnitus;Tinnitus patients * Any symptoms of migraine, cluster headache, chronic tension type headache or medication overuse headache * (History of) ophthalmological disease other than refraction error;Healthy controls * Any symptoms of migraine, cluster headache, chronic tension type headache or medication overuse headache * (History of) ophthalmological disease other than refraction error * (History of) chronic tinnitus

Design outcomes

Primary

MeasureTime frame
1. Detailed clinical information on different visual symptoms, non-visual symptoms, triggers, (psychiatric and neurological) comorbidities and psychological well-being; including data from prospective follow-up. 2. Quantitative data on visual sensitivity and EEG and VEP profiles with specific parameters (amplitude of the posterior dominant rhythm, photic drive response); including diagnostic test characteristics. 3. Concentrations of multiple metabolites both in vivo (MRS) and ex vivo (blood, urine).

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)